Back

dr. ir. F.H. van der Baan

dr. ir. F.H. van der Baan

Assistant Professor

Show full profile

Research Output (30)

Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Peterlongo Paolo, Chang-Claude Jenny, Moysich Kirsten B., Rudolph Anja, Schmutzler Rita K., Simard Jacques, Soucy Penny, Eeles Rosalind A., Easton Douglas F., Hamann Ute, Wilkening Stefan, Chen Bowang, Rookus Matti A., Schmidt MarjankaK., van der Baan Frederieke H., Spurdle Amanda B., Walker Logan C., Lose Felicity, Maia Ana-Teresa, Montagna Marco, Matricardi Laura, Lubinski Jan, Jakubowska Anna, Garcia Encarna B. Gomez, Olopade Olufunmilayo I., Nussbaum Robert L., Nathanson Katherine L., Domchek Susan M., Rebbeck Timothy R., Arun Banu K., Karlan Beth Y., Orsulic Sandra, Lester Jenny, Chung Wendy K., Miron Alex, Southey Melissa C., Goldgar David E., Buys Saundra S., Janavicius Ramunas, Dorfling Cecilia M., van Rensburg Elizabeth J., Ding Yuan Chun, Neuhausen Susan L., Hansen Thomas V. O., Gerdes Anne-Marie, Ejlertsen Bent, Jonson Lars, Osorio Ana, Martinez-Bouzas Cristina, Ausems Margreet G. E. M., , , , Jan 2015, In: Cancer Epidemiology Biomarkers & Prevention. 24 , p. 308-316 9 p.

Optimizing trial design in pharmacogenetics research:comparing a fixed parallel group, group sequential, and adaptive selection design on sample size requirements

Boessen R., van der Baan F.H., Groenwold R.H.H., Egberts A.C.G., Klungel O.H., Grobbee D.E., Knol M.J., Roes K.C.B. 12 Nov 2013, In: Pharmaceutical Statistics. 12 , p. 366-374 9 p.

Added value of pharmacogenetic testing in predicting statin response:results from the REGRESS trial

van der Baan F.H., Knol M.J., Maitland-van der Zee A.H., Regieli J.J., van Iperen E.P., Egberts A.C.G., Klungel O.H., Grobbee D.E., Jukema J.W. Aug 2013, In: The Pharmacogenomics Journal. 13 , p. 318-24 7 p.

Consent in psychiatric biobanks for pharmacogenetic research.

van der Baan F.H., Bernabe R.D.L.C., Bredenoord A.L., Gregoor J.G., Meynen G., Knol M.J., van Thiel G.J.M.W. 2013, In: International Journal of Neuropsychopharmacology. 16 , p. 677-682 6 p.

Personalized Medicine : Pharmacogenetic Testing in Drug Development and Clinical Practice

van der Baan F.H. 28 Jun 2012, 163 p.

Potential of adaptive clinical trial designs in pharmacogenetic research.

van der Baan F.H., Knol M.J., Klungel O.H., Egberts A.C.G., Grobbee D.E., Roes C.B. 2012, In: Pharmacogenomics. 13 , p. 571-578 8 p.

Pharmacogenetics in randomized controlled trials:considerations for trial design

van der Baan F.H., Klungel O.H., Egberts A.C.G., Leufkens H.G.M., Grobbee D.E., Roes K.C.B., Knol M.J. 2011, In: Pharmacogenomics. 12 , p. 1485-92 8 p.

Suitable Study Designs for Pharmacogenetic Research

van der Baan F.H., Klungel O.H., Grobbee D.E., Egberts A.C.G., Knol M.J. 2010, p. S90, 210 2 p.

Impact of a Safety Issue on the Number and Type of Publications: The Example of Sertindole

van der Baan F.H., Knol M.J., de Bruin M.L., Leufkens H.G.M., Klungel O.H., Egberts A.C.G. 2009, In: Pharmacoepidemiology and Drug Safety. 18 , p. S170 1 p.

Hemoglobin variability in patients with chronic kidney disease in the Netherlands

van der Putten K., van der Baan F.H., Schellekens H., Gaillard C.A.J.M. 2009, In: International Journal of Artificial Organs. 32 , p. 787-793 7 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not